Company Filing History:
2 out of 12 
1 out of 1,380 
Years Active: 2020-2021
Title: Laura Rosa Brunet: Innovator in Cancer Therapy
Introduction
Laura Rosa Brunet is a prominent inventor based in Uxbridge, GB. She has made significant contributions to the field of cancer therapy, particularly through her innovative patents. With a total of 2 patents, her work focuses on immunomodulators and their applications in treating neoplastic diseases.
Latest Patents
Brunet's latest patents include a checkpoint inhibitor and a whole cell for use in cancer therapy. This immunomodulator is designed for the treatment, reduction, inhibition, or control of neoplastic diseases in patients undergoing checkpoint inhibition therapy. The invention targets CTLA-4, PD-1, PD-L1, and combinations thereof, allowing for simultaneous, separate, or sequential administration of the immunomodulator. Additionally, she has developed compounds for use in the treatment of sepsis and the prevention or treatment of post-sepsis syndrome.
Career Highlights
Throughout her career, Laura Rosa Brunet has worked with notable organizations, including Immodulon Therapeutics Limited and the University of Colorado. Her expertise in immunotherapy has positioned her as a key figure in the development of innovative treatments for serious health conditions.
Collaborations
Brunet has collaborated with esteemed colleagues such as Charles Akle and Christopher A. Lowry. These partnerships have further enhanced her research and development efforts in the field of cancer therapy.
Conclusion
Laura Rosa Brunet's contributions to cancer therapy through her innovative patents and collaborations highlight her dedication to advancing medical science. Her work continues to inspire and pave the way for future breakthroughs in the treatment of neoplastic diseases.